Search research articles
Contact Us
Filters
Showing results (51-60 of 403) with videos related to
Page
of 41
Sort By:
Neurology
|
April 1, 1984
Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome
J Newsom-Davis, N M Murray
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 19, 2017
Regression of Paraneoplastic Rash after Lung Cancer Chemotherapy
David J Pinato, Thomas Newsom-Davis
Neurology
|
March 1, 1981
Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission
N M Murray, J Newsom-Davis
Journal of Immunological Methods
|
January 1, 1982
Purification of anti-acetylcholine receptor antibody from patients with myasthenia gravis
B Lang, A Vincent, J Newsom-Davis
The New England Journal of Medicine
|
November 26, 1981
Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes
J Newsom-Davis, N Willcox, L Calder
Neuromuscular Disorders : NMD
|
May 1, 1993
Congenital myasthenic syndromes
P Shillito, A Vincent, J Newsom-Davis
Journal of the Neurological Sciences
|
March 1, 1988
Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect
S Mossman, A Vincent, J Newsom-Davis
Ciba Foundation Symposium
|
January 1, 1982
Acetylcholine receptor antibody: clinical and experimental aspects
J Newsom-Davis, A Vincent, N Willcox
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1983
Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis
S Wilson, A Vincent, J Newsom-Davis
Lancet (London, England)
|
January 18, 1986
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity
S Mossman, A Vincent, J Newsom-Davis
Page
of 41
Search research articles
Search
Showing results (51-60 of 403) with videos related to
Sort By:
Page
of 41
Neurology
|
April 1, 1984
Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome
J Newsom-Davis, N M Murray
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 19, 2017
Regression of Paraneoplastic Rash after Lung Cancer Chemotherapy
David J Pinato, Thomas Newsom-Davis
Neurology
|
March 1, 1981
Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission
N M Murray, J Newsom-Davis
Journal of Immunological Methods
|
January 1, 1982
Purification of anti-acetylcholine receptor antibody from patients with myasthenia gravis
B Lang, A Vincent, J Newsom-Davis
The New England Journal of Medicine
|
November 26, 1981
Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes
J Newsom-Davis, N Willcox, L Calder
Neuromuscular Disorders : NMD
|
May 1, 1993
Congenital myasthenic syndromes
P Shillito, A Vincent, J Newsom-Davis
Journal of the Neurological Sciences
|
March 1, 1988
Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect
S Mossman, A Vincent, J Newsom-Davis
Ciba Foundation Symposium
|
January 1, 1982
Acetylcholine receptor antibody: clinical and experimental aspects
J Newsom-Davis, A Vincent, N Willcox
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1983
Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis
S Wilson, A Vincent, J Newsom-Davis
Lancet (London, England)
|
January 18, 1986
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity
S Mossman, A Vincent, J Newsom-Davis
Page
of 41